tetracycline hydrochloride: Clinical Trials

4 trials of tetracycline hydrochloride, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 withdrawn. 2 Phase 2, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Not applicable1Completed 1

Follow tetracycline hydrochloride: new trials by email Literature Review of tetracycline hydrochloride trials Research Report on tetracycline hydrochloride

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
S0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307
clodronate disodium, demeclocycline hydrochloride, ibandronate sodium - Breast Cancer
WithdrawnSWOG Cancer Research Network2008-10-012013-04-10
Tetracycline in Preventing Skin Rash in Patients Who Are Receiving Drugs Such as Gefitinib and Cetuximab for Cancer
tetracycline hydrochloride, placebo - Unspecified Adult Solid Tumor, Protocol Specific
Not applicableCompletedAlliance for Clinical Trials in Oncology1302004-12-012017-03-16
Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma
bismuth subcitrate, amoxicillin, clarithromycin - Lymphoma
Phase 2CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC961997-09-012012-07-02
Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach
Amoxicillin, Bismuth Subsalicylate, Clarithromycin - Lymphoma
Phase 2CompletedM.D. Anderson Cancer Center51995-08-102018-10-24

Conditions studied

Lymphoma (2)  ·  Lymphoma, B-Cell, Marginal Zone (2)  ·  Breast Neoplasms (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)

Sponsors

Alliance for Clinical Trials in Oncology (1)  ·  European Organisation for Research and Treatment of Cancer - EORTC (1)  ·  M.D. Anderson Cancer Center (1)  ·  SWOG Cancer Research Network (1)

Countries

United States (3)  ·  United Kingdom (1)

Top investigators

Aminah Jatoi, MD (1)  ·  Dawn Hershman, MD (1)  ·  Gideon Steinbach, MD, PhD (1)  ·  John W. Sweetenham, MD (1)  ·  Patrice P. Carde, MD (1)

Results publications

PMID 18543329, PMID 20820817

NIH funding

P30CA016672 (1), U10CA032102 (1)